GUGGENHEIM CAPITAL LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,733
-83.1%
21,572
-62.1%
0.00%
-100.0%
Q2 2023$270,648
-17.6%
56,859
-1.3%
0.00%
-33.3%
Q1 2023$328,304
-73.1%
57,597
-52.4%
0.00%
-72.7%
Q4 2022$1,220,053
-57.2%
120,917
-5.0%
0.01%
-57.7%
Q3 2022$2,851,000
-17.8%
127,218
-9.1%
0.03%
-3.7%
Q2 2022$3,468,000
-32.4%
139,974
+5.7%
0.03%
-12.9%
Q1 2022$5,132,000
-44.1%
132,375
-15.6%
0.03%
-35.4%
Q4 2021$9,179,000
+10.9%
156,888
+12.3%
0.05%
-4.0%
Q3 2021$8,278,000
-8.4%
139,663
+34.1%
0.05%
-5.7%
Q2 2021$9,041,000
+3.5%
104,174
-1.7%
0.05%
-7.0%
Q1 2021$8,734,000
+3.9%
105,930
+14.6%
0.06%
+7.5%
Q4 2020$8,403,000
+260.5%
92,408
+58.5%
0.05%
+211.8%
Q3 2020$2,331,000
+16.0%
58,308
-0.4%
0.02%
+6.2%
Q2 2020$2,009,000
+167.2%
58,558
+72.9%
0.02%
+100.0%
Q1 2020$752,000
+92.3%
33,868
+69.6%
0.01%
+166.7%
Q4 2019$391,000
+98.5%
19,965
+57.8%
0.00%
+50.0%
Q3 2019$197,000
+358.1%
12,653
+19.0%
0.00%
Q3 2017$43,000
+30.3%
10,636
+3.3%
0.00%
Q2 2017$33,00010,3000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders